Learn more about Peter Attia’s digital program
#210 – Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.
“I think we should advise people to measure Lp(a); that would be a gigantic step.” —Benoît Arsenault
For triglycerides, “normal” may not be “optimal”
How do triglyceride levels relate to cardiovascular risk?
Intro to lipids & lipoproteins: why there is no ‘bad’ or ‘good’ cholesterol
I recently posted on Twitter about my frustration with the way the press writes about “good” and “bad” cholesterol, and…
Peter on the four horsemen of chronic disease
This audio clip is from AMA #14: What lab tests can (and cannot) inform us about our overall objective of…
#203 – AMA #34: What Causes Heart Disease?
“Not everybody dies from atherosclerosis, but… everybody dies with it.” — Peter Attia
When CAC Tests Are Useful and When They Are Not
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we…
Peter on why early prevention of atherosclerosis is critical
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we…
Preventing Atherosclerosis: 2 Fatal Flaws with the “10 Year Risk” Approach
This video clip is from episode #185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way…
Peter on how early and aggressive lowering of apoB could change the course of ASCVD
This audio clip is from episode #202 – Peter on nutrition, disease prevention, sleep, and more, originally released on April…
#202 – Peter on nutrition, disease prevention, sleep, and more — looking back on the last 100 episodes
“I really think that in 10 years we’re going to basically be using designer-based immunotherapies to eradicate most solid organ metastatic cancers.” —Peter Attia